Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Juva Life Inc. (JUVA.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.1200+0.0050 (+4.35%)
At close: 01:36PM EST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1150
Open0.1050
Bid0.1000 x N/A
Ask0.1300 x N/A
Day's Range0.1050 - 0.1200
52 Week Range0.0850 - 0.4400
Volume45,937
Avg. Volume21,781
Market Cap19.682M
Beta (5Y Monthly)0.80
PE Ratio (TTM)N/A
EPS (TTM)-0.0710
Earnings DateSep 06, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for JUVA.CN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Juva Life Begins Construction on Redwood City Retail Storefront, On Track to Open in Early 2023

      Company Was Previously the Highest-Scoring Applicant During the Permitting Process in Redwood City, CaliforniaVANCOUVER, British Columbia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva,” or the “Company”), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today that the Company has started construction on their upcoming Redwoo

    • GlobeNewswire

      Juva Life Successfully Scales Novel Compound JUVA-041 for Preclinical Studies and Eventual Commercialization, Highlighting Successful Chemistry Process

      Company Reports Successful Medicinal Chemistry Effort to Scale Up Small Molecule Isolated from Cannabis Plant to Support Preclinical and Non-Clinical StudiesVANCOUVER, British Columbia, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva,” or the “Company”), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, today announced the successful scal

    • GlobeNewswire

      Juva Life Announces Flōs, New Branded Cannabis Flower Product Line

      New Branded Cannabis Product Line Diversifies Company Product Offerings; Compliments Pharmaceutical ResearchVANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today the launch of the Company’s new product line, Flōs, a branded line of flo

    Advertisement
    Advertisement